Endo has reached a settlement with the remaining plaintiffs in an antitrust lawsuit over the Lidoderm pain patch on the eve of jury selection for an upcoming trial, court records show, an effort to end the case after a California federal judge refused to enter judgment in its favor.
Endo International PLC struck the deal with the plaintiffs after a settlement conference before a magistrate judge on Feb. 13, according to a stipulation filed Wednesday that did not disclose the terms of the agreement. A representative of the company declined to comment Thursday, saying that it would discuss the settlement during a Tuesday earnings call.
Endo was the last remaining defendant in the case after the plaintiffs reached settlements with defendants Teikoku and a domestic subsidiary in the last few months. Endo had earlier settled with a handful of big name retailers, including Walgreen Co. and CVS Pharmacy Inc., but hadn’t come to an agreement with a group of direct purchaser plaintiffs and end-payor plaintiffs.